The Sofusa™ platform began with a technological breakthrough, which inspired a vision, that led to a mission. Learn more about the Sofusa™ story and how it represents a landmark opportunity to revolutionize the way parenteral medicines are developed.Learn More
July 3, 2018
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation ...Read More
June 22, 2017
Visit the Sofusa™ technical team to discuss opportunities for our novel drug delivery system at the BIO International exhibit (Booth 3131) in San Diego, CA.